Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TARDBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTERF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRB14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS15A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JADE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPSM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPHOSPH9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507855 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDH3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on